阿普辛尼
NADPH氧化酶
氧化应激
烟酰胺腺嘌呤二核苷酸磷酸
内科学
心房颤动
化学
氧化酶试验
糖尿病性心肌病
内分泌学
氧化磷酸化
线粒体
医学
药理学
线粒体ROS
生物化学
心肌病
心力衰竭
酶
作者
Lingling Zhou,Liu Yang,Zhaojia Wang,Daiqi Liu,Bingxin Xie,Yue Zhang,Meng Yuan,Gary Tse,Guangping Li,Yugang Dong,Tong Liu
出处
期刊:Life Sciences
[Elsevier]
日期:2021-05-01
卷期号:272: 119240-119240
被引量:12
标识
DOI:10.1016/j.lfs.2021.119240
摘要
The mechanisms of atrial fibrillation (AF) in diabetes mellitus (DM) involve a complex interplay between increased oxidative stress, mitochondrial dysfunction and atrial remodeling. In this study, we examined the effects of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation on mitochondrial oxidative stress and atrial remodeling in a rabbit model of diabetes mellitus (DM). Healthy rabbits were selected and randomly divided into control, diabetic and apocynin administration group. Parameters of echocardiography, atrial electrophysiology, oxidative stress and mitochondrial function were compared between the different groups. Compared to the control group, the DM group showed higher activity of NADPH oxidase, increased oxidative stress, larger left atrial diameter, a reduction in atrial mean conduction velocity. These findings were associated with increased interstitial fibrosis of the atria and higher atrial fibrillation (AF) inducibility. Moreover, atrial ultrastructure and mitochondrial function such as the mitochondrial respiratory control rate (RCR) were impaired. NADPH oxidase inhibition using the pharmacological agent apocynin improved these changes. NADPH oxidase activity plays an important role in mitochondrial oxidative stress, which is associated with AF inducibility by promoting adverse atrial remodeling. The NADPH oxidase inhibitor apocynin can prevent these pathological changes and may be a potential drug for AF treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI